Skip to main content
. Author manuscript; available in PMC: 2011 Feb 15.
Published in final edited form as: Brain Res Bull. 2009 Nov 6;81(2-3):310. doi: 10.1016/j.brainresbull.2009.10.018

Figure 8.

Figure 8

The effect of topical nepafenac on the severity of OIR in the rat. 0.1% nepafenac, given QID or BID from P14-P19, significantly reduced (* p ≤ 0.001) OIR-induced retinal NV. Each bar represents the mean ± SEM.